MENU
ARCT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Arcturus Therapeutics Holdings (ARCT) Earnings Date & Reports

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases... Show more

A.I. Advisor
published Earnings

ARCT is expected to report earnings to fall 973.47% to $4.28 per share on March 02

Arcturus Therapeutics Holdings ARCT Stock Earnings Reports
Q4'25
Est.
$4.28
Q3'25
Missed
by $6.02
Q2'25
Missed
by $3.55
Q1'25
Missed
by $4.11
Q4'24
Missed
by $0.92
The last earnings report on November 10 showed earnings per share of -49 cents, missing the estimate of $5.53. With 239.56K shares outstanding, the current market capitalization sits at 184.68M.
View a ticker or compare two or three
ARCT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ARCT showed earnings on November 10, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of technology and therapeutics for rare diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
10628 Science Center Drive
Phone
+1 858 900-2660
Employees
180
Web
https://www.arcturusrx.com